Abstract
Moyamoya vasculopathy (MMV) is a stenoocclusive cerebrovascular disease frequently affecting adolescent females. Thus, the management of pregnancy is of major interest for physicians dealing with MMV patients. However, clinical data concerning pregnant MMV patients is lacking. Our aim was to analyze the course of pregnancy in our European MMV patient cohort. We retrospectively identified MMV patients with a history of pregnancy who were treated in our institution. We analyzed demographic data, clinical symptoms, treatment, and detailed history of pregnancies. We identified 31 MMV patients (81% moyamoya disease (MMD), 6% unilateral MMD, 13% quasi MMD) with a history of pregnancy resulting in a total of 60 pregnancies and 48 deliveries. Ninety-four percent of the patients became symptomatic by ischemic events and 6% by headache. Eighty-one and nineteen percent of the patients experienced their pregnancies prior to (first group) or after the diagnosis (second group), respectively. In the first group, the mean age at first delivery and bypass treatment were 24 ± 4 and 42 ± 10, respectively. Eight percent of these patients were diagnosed as MMV due to ischemic events during perinatal period. In the second group, the mean age at first delivery and bypass treatment were 26 ± 7 and 23 ± 6, respectively. No cerebral events were reported within perinatal period in this group. All previously operated patients continued their aspirin medication at least until the 3rd trimester. The majority of the pregnancies occurred prior to diagnosis in our European patient cohort. Our data indicates a protective effect of surgical treatment for avoiding cerebral events during pregnancy and delivery for already diagnosed patients.
Similar content being viewed by others
References
Acker G, Goerdes S, Schmiedek P, Czabanka M, Vajkoczy P (2016) Characterization of clinical and radiological features of quasi-moyamoya disease among European Caucasians including surgical treatment and outcome. Cerebrovasc Dis 42:464–475. https://doi.org/10.1159/000448812
Acker G, Goerdes S, Schneider UC, Schmiedek P, Czabanka M, Vajkoczy P (2015) Distinct clinical and radiographic characteristics of moyamoya disease amongst European Caucasians. Eur J Neurol 22:1012–1017. https://doi.org/10.1111/ene.12702
Ahn IM, Park D-H, Hann HJ, Kim KH, Kim HJ, Ahn HS (2014) Incidence, prevalence, and survival of moyamoya disease in Korea: a nationwide, population-based study. Stroke 45:1090–1095. https://doi.org/10.1161/STROKEAHA.113.004273
Amin-Hanjani S, Kuhn M, Sloane N, Chatwani A (1993) Moyamoya disease in pregnancy: a case report. Am J Obstet Gynecol 169:395–396
Anthony J, Damasceno A, Ojjii D (2016) Hypertensive disorders of pregnancy: what the physician needs to know. Cardiovasc J Afr 27:104–110. https://doi.org/10.5830/CVJA-2016-051
Chen P-C, Yang S-H, Chien K-L, Tsai IJ, Kuo M-F (2014) Epidemiology of moyamoya disease in Taiwan: a nationwide population-based study. Stroke 45:1258–1263. https://doi.org/10.1161/STROKEAHA.113.004160
Fukushima K, Yumoto Y, Kondo Y, Fujita Y, Morokuma S, Tsukimori K, Wake N (2012) A retrospective chart review of the perinatal period in 22 pregnancies of 16 women with Moyamoya disease. J Clin Neurosci: Off J Neurosur Soc Australas 19:1358–1362. https://doi.org/10.1016/j.jocn.2011.12.021
Gimovsky AC, Macri CJ, Bathgate SL, Ross DE (2012) Moyamoya disease in pregnancy: management after intracranial bypass grafting. Case Rep Obstet Gynecol 2012:638471. https://doi.org/10.1155/2012/638471
Guzman R, Lee M, Achrol A, Bell-Stephens T, Kelly M, Do HM, Marks MP, Steinberg GK (2009) Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg 111:927–935. https://doi.org/10.3171/2009.4.JNS081649
Hoshino H, Izawa Y, Suzuki N (2012) Epidemiological features of moyamoya disease in Japan. Neurol Med Chir (Tokyo) 52:295–298
Jennett WB, Cross JN (1967) Influence of pregnancy and oral contraception on the incidence of strokes in women of childbearing age. Lancet 1:1019–1023
Jung YJ, Kim MA, Kwon JY, Lee HR, Cho HY, Park YW, Kim YH (2015) Pregnancy outcomes in women with moyamoya disease: experiences at a single center in Korea. Yonsei Med J 56:793–797. https://doi.org/10.3349/ymj.2015.56.3.793
Kraemer M, Berlit P, Diesner F, Khan N (2012) What is the expert’s option on antiplatelet therapy in moyamoya disease? Results of a worldwide survey. Eur J Neurol 19:163–167. https://doi.org/10.1111/j.1468-1331.2011.03481.x
Lee SU, Chung YS, CW O, Kwon OK, Bang JS, Hwang G, Kim T, Ahn SY (2016) Cerebrovascular events during pregnancy and puerperium resulting from preexisting moyamoya disease: determining the risk of ischemic events based on hemodynamic status assessment using brain perfusion single-photon emission computed tomography. World Neurosurg 90:66–75. https://doi.org/10.1016/j.wneu.2016.02.062
Lindheimer MD, Taler SJ, Cunningham FG (2008) Hypertension in pregnancy. J Am Soc Hypertens: JASH 2:484–494. https://doi.org/10.1016/j.jash.2008.10.001
Ma JC, Burlingame JM (2011) Moyamoya disease in pregnancy: a case series and review of management options. Hawaii Med J 70:161–163
Miao W, Zhao P-L, Zhang Y-S, Liu H-Y, Chang Y, Ma J, Huang Q-J, Lou Z-X (2010) Epidemiological and clinical features of moyamoya disease in Nanjing, China. Clin Neurol Neurosurg 112:199–203. https://doi.org/10.1016/j.clineuro.2009.11.009
Miyamoto S, Yoshimoto T, Hashimoto N, Okada Y, Tsuji I, Tominaga T, Nakagawara J, Takahashi JC, Investigators JAMT (2014) Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial. Stroke 45:1415–1421. https://doi.org/10.1161/STROKEAHA.113.004386
Research Committee on the P, Treatment of Spontaneous Occlusion of the Circle of W, Health Labour Sciences Research Grant for Research on Measures for Infractable D (2012) Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo) 52:245–266
Sato K, Yamada M, Okutomi T, Kato R, Unno N, Fujii K, Kumabe T (2015) Vaginal delivery under epidural analgesia in pregnant women with a diagnosis of moyamoya disease. J Stroke Cerebrovasc Dis: Off J National Stroke Assoc 24:921–924. https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.11.030
Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R (2010) Pre-eclampsia. Lancet 376:631–644. https://doi.org/10.1016/S0140-6736(10)60279-6
Suzuki J, Takaku A (1969) Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20:288–299
Takahashi JC, Ikeda T, Iihara K, Miyamoto S (2012) Pregnancy and delivery in moyamoya disease: results of a nationwide survey in Japan. Neurol Med Chir (Tokyo) 52:304–310
Tanaka H, Katsuragi S, Tanaka K, Miyoshi T, Kamiya C, Iwanaga N, Neki R, Takahashi JC, Ikeda T, Yoshimatsu J (2015) Vaginal delivery in pregnancy with moyamoya disease: experience at a single institute. J Obstet Gynaecol Res 41:517–522. https://doi.org/10.1111/jog.12557
Thornton P, Douglas J (2010) Coagulation in pregnancy. Best Pract Res Clin Obstet Gynaecol 24:339–352. https://doi.org/10.1016/j.bpobgyn.2009.11.010
Wiebers DO (1985) Ischemic cerebrovascular complications of pregnancy. Arch Neurol 42:1106–1113
Yamada S, Oki K, Itoh Y, Kuroda S, Houkin K, Tominaga T, Miyamoto S, Hashimoto N, Suzuki N, Research Committee on Spontaneous Occlusion of Circle of W (2016) Effects of surgery and antiplatelet therapy in ten-year follow-up from the registry study of research committee on moyamoya disease in Japan. J Stroke Cerebrovasc Dis: Off J National Stroke Assoc 25:340–349. https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.10.003
Acknowledgements
Dr. Acker is a participant of the BIH-Charité Clinician Scientist Program funded by the Charité – Universitätsmedizin Berlin and the Berlin Institute of Health.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (Number EA1/178/14) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
For this type of study, formal consent is not required.
Rights and permissions
About this article
Cite this article
Acker, G., Czabanka, M., Schmiedek, P. et al. Pregnancy and delivery in moyamoya vasculopathy: experience of a single European institution. Neurosurg Rev 41, 615–619 (2018). https://doi.org/10.1007/s10143-017-0901-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10143-017-0901-5